TrialMind

TrialMind is an agentic AI platform developed by Keiji AI, designed to support the full clinical trial lifecycle — from target identification and trial design through to patient recruitment, data monitoring, and regulatory reporting. The platform is built for pharmaceutical companies, biotechs, contract research organizations (CROs), and academic medical centers conducting real-world clinical research.

TrialMind is built on over 10 years of AI research in drug discovery and development, with work published in Nature, Nature Biomedical Engineering, Nature Communications, and top AI venues including NeurIPS. The platform includes 10+ specialized AI agents, 100+ proprietary MCP tools, and access to over 1 million trial data points spanning all six clinical research stages.

Clinical Trial Lifecycle Coverage

• Discovery: Target and mechanism identification to support early-stage research.
• Trial Design: Protocol optimization and modeling to refine study parameters.
• Real-World Data Analysis: Extraction of insights from real-world data sources.
• Site Selection: Patient matching and site selection to support trial initiation.
• Literature Review: Meta-analysis and evidence synthesis across published research.
• Digital Twin: Prognostic scoring and patient simulation capabilities.
• Data Monitoring: On-demand safety monitoring during trial execution.
• Biostatistical Analysis: Statistical modeling and programming support.
• Outcome Prediction: Forecasting of trial success probabilities.

Platform Capabilities and Performance

• Supports all six clinical research stages: Discovery, Planning, Initiation, Execution, Analysis, and Reporting.
• Includes vertical AI agents purpose-built for clinical research tasks, distinct from general-purpose language models.
• Validated performance benchmarks show TrialMind outperforming general-purpose models across multiple tasks, including knowledge-intensive biomedical reasoning (HLE-Medicine), literature question answering (LabBench-LitQA2), scientific reasoning (SuperGPQA-Hard), target identification, mechanism of action and pathway reasoning, and in vivo flux response prediction.
• Benchmark comparisons sourced from DeepEvidence (arXiv, 2025) indicate performance multiples of up to 12× over comparable models on specific biomedical reasoning tasks.

Enterprise Deployment and Compliance

• Deployed by top 20 pharma companies, biotechs, CROs, and academic medical centers.
• Holds certifications relevant to regulated healthcare environments, including SOC 2, HIPAA, GxP, and ISO 27001.
• Reported to have achieved 5× year-over-year growth and multi-million-dollar ARR across its enterprise customer base.